Great. Thank you.
I'm glad that's been thought about.
I hear criticism for moving towards pharmacare from some of the pharmaceutical companies themselves. I don't know if I believe this, or how widely spread this is believed, but the position has been brought forward to me that pharmaceutical companies need certain countries to pay more because it funds their research and development.
I'm not so sure that this is the case. I believe that if everybody had access to medication it would actually create a larger market.
Has your organization thought about this at all? Is this something that has been raised, or is it just a minor issue that has not really been brought forward in this country?